• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Alcon Research, LLC - Huntington Clareon Aspheric UV Absorbing IOL; Intraocular Lens

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Alcon Research, LLC - Huntington Clareon Aspheric UV Absorbing IOL; Intraocular Lens Back to Search Results
Model Number CC60WF
Medical Device Problem Code Scratched Material (3020)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/30/2026
Type of Reportable Event Malfunction
Event or Problem Description
A non-health care professional reported that during the intraocular lens (iol) implantation surgery, a scratch was noticed on the lens optic.Additional information was received stating that, the scratch was not observed prior to loading, and it was unknown if it occurred prior to handling, during loading, or during injection.The lens was removed and replaced during the same procedure and the surgery was completed on the same day.There was no patient harm.
 
Additional Manufacturer Narrative
The lens was returned for evaluation.Dried solution is observed on the lens.A deep scrape mark is observed on the center of the optic on the anterior side.Scratches are observed on the anterior surface of the optic.The lens was cut into three pieces, typical of removal from the eye.Marks are observed on both sides of the optic that are similar to those left by a surgical instrument used to grasp the lens.A batch record review and a non-conformance review of the reported lot number was conducted.The deviation review did not reveal any potential contributing factors to the reported complaint and all corresponding production release specifications defined in the medical device file were met.Qualified associated products were indicated.The reported scratch was observed on the center of the optic.All lenses are 100 percent inspected for cosmetic attributes and the damage exhibited by the returned complaint sample would not have met alcon¿s release criteria.Based on our observation, it can be reasonably concluded that the damage is not manufacturing related.Due to the presence of surgical solution and the condition of the returned sample, the damage is most likely related to customer handling.The instructions for use (ifu) instructs: using holding forceps, grasp the lens by the optic edge and gently place the lens anterior side up into the back of the opthalmic viscoelastic device (ovd)-filled cartridge.The lens should be inserted until the optic is a little more than half-way inside the cartridge.Use the holding forceps to gently push down on the lens, verifying that the lens is on the bottom surface of the cartridge.Using holding forceps, take the trailing haptic, and gently fold the haptic onto the anterior side of the optic.Slowly grip or push the optic edge to position the lens as far into the cartridge as the forceps will permit, while ensuring the lens remains on the bottom surface of the cartridge and the trailing haptic remains on the optic.Failure to follow these steps may cause the lens to advance incorrectly causing delivery issues and/or damage.Follow the section regarding directions for use for information on the maximum allowed time for the intraocular lens (iol) to stay in the folded condition.Failure to adhere to manufacturer¿s recommendations may result in iol damage.During lens loading and insertion, do not allow the company iol to remain in a folded condition within the selected iol delivery system for more than 3 minutes prior to completing insertion into the capsular bag.The investigation has been completed based on current information.Receipt of additional relevant information or supporting materials will prompt a re-evaluation of the complaint investigation.Complaints are reviewed and monitored for adverse trends on a monthly basis.No adverse trends have been observed associated with the reported product and event.No further action has been identified for this reported event.Quality assurance has reviewed this complaint and will continue to monitor data for evidence of adverse trending and take further action, as appropriate.No further action is warranted at this time.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
Clareon Aspheric UV Absorbing IOL
Common Device Name
Intraocular Lens
Manufacturer (Section D)
Alcon Research, LLC - Huntington
246 kyle lane
huntington WV 25702
Manufacturer (Section G)
Alcon Research, LLC - Huntington
246 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
+1(800)757-9780
MDR Report Key50815169
Report Number1119421-2026-01902
Device Sequence Number13431180
Product Code HQL
UDI-Device Identifier00380652396936
UDI-Public(01)00380652396936(17)291203(11)251205(10)16157784
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P190018
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 09/18/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberCC60WF
Device Lot Number16157784
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer09/09/2026
Is the Reporter a Health Professional? No
Initial Date Received by Manufacturer 08/26/2026
Initial Report FDA Received Date09/18/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured12/05/2025
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
MONARCH II Loading Forceps.; MONARCH III Cartridge D.; MONARCH III Injector.; PROVISC Ophthalmic ViscoSurgical Device.
Patient Age68 YR
Patient SexFemale
-
-